Emory School of Medicine
Dr. Dong obtained his Medical Degree in 1999 and PhD in 2004 at Peking University in China, and then joined the Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University as a postdoctoral fellow. He completed his postdoctoral training in 2008 and was promoted to an Instructor and, at the end of 2010, to an Assistant Professor at the same institution. Dr. Dong has published extensively in peer-reviewed scientific journals and obtained multiple awards. He also serves as a manuscript reviewer for many journals in the field of cancer research.
Dr. Dong’s research interests have always been in identifying molecules that transform normal cells to cancer cells and cause metastasis. He has focused on the discovery of oncogenes and tumor suppressor genes that are responsible for tumorigenesis and metastasis. He has reported the first tumor-specific membrane antigen CP1, which is an ideal target for cancer therapy, and has identified and characterized many new oncogenes and tumor suppressor genes in human cancer, including CT43, CT44, BJ-TSA-9, BJ-HCC-25, FOXO1A, U50 and ATBF1. Further molecular characterization and preclinical validation of these oncogenes and tumor suppressor genes are underway using in vitro and in vivo cancer models.
View publications on PubMed